Economics and Serendipity | GenomeWeb

By now, you've probably read several blog post and articles that make arguments for why research data and software should be free and open to all — we figure one more won't hurt.

In a recent post, an Ensembl outreach officer makes a case for why Ensembl's data and code are open source and open access that is based on economics and chance.

Economically speaking, making everything open saves time, money, and infrastructure and just makes for more efficient research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.